Skip to main content
. Author manuscript; available in PMC: 2016 Jun 15.
Published in final edited form as: Cancer. 2015 Mar 17;121(12):1977–1984. doi: 10.1002/cncr.29323

Table 3. Treatment of recurrence1.

HPV-positive N=78 HPV-negative N=28 p-value
Any Salvage Therapy 0.12
Yes 72 (92.3%) 22 (78.6%)
No 3 (3.8) 2 (7.1)
Unknown 3 (3.8) 4 (14.2)
Surgical salvage2 0.25
Yes 49 (68.1) 12 (54.5)
No 23 (31.9) 10 (45.5)
Surgery only 16 (32.7) 2 (16.7) 0.28
Surgery + adjuvant 33 (67.3) 10 (83.3)
Non-surgical salvage
Chemotherapy only 9 (39.1) 6 (60.0) 0.25
Radiation only 5 (21.7) 3 (30.0)
Chemoradiation 9 (39.1) 1 (10.0)
1

Patients with metastatic disease at primary diagnosis were excluded, n=106

2

n=94, treated patients only